Cardio Diagnostics Holdings, Inc. (CDIO) vs Lucyd, Inc (LUCY)
A side-by-side comparison of Cardio Diagnostics Holdings, Inc. and Lucyd, Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDIO
Cardio Diagnostics Holdings, Inc.
$2.04HealthcareDelayed quote: Oct 6, 2026, 12:23 PM EDT
LUCY
Lucyd, Inc
$0.92HealthcareDelayed quote: Oct 6, 2026, 12:22 PM EDT
Total return — CDIO vs LUCY
growth of $100 · dividends reinvested · last 4yCDIO -99.3% (-71.2%/yr)LUCY -99.2% (-70.5%/yr)LUCY compounded faster over this window
CDIO LUCY
CDIO vs LUCY: by the numbers
- •CDIO is the larger company ($6M vs $6M market cap).
- •Both run net losses; LUCY's is the smaller (-225.28% vs -44771.83% net margin).
Metrics side by side
Valuation
| Metric | CDIO | LUCY |
|---|---|---|
| P/S ratio | 417.81 | 1.70 |
| P/B ratio | 0.81 | 0.84 |
Profitability
| Metric | CDIO | LUCY |
|---|---|---|
| Gross margin | 100.00% | 22.79% |
| Operating margin | -43737.46% | -319.16% |
| Net margin | -44771.83% | -225.28% |
| ROE | -87.12% | -111.42% |
| ROIC | -82.84% | -122.15% |
Growth (annualized)
| Metric | CDIO | LUCY |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 64.52% |
Go deeper
Dig into the metrics
Cardio Diagnostics ROELucyd ROECardio Diagnostics operating marginLucyd operating marginCardio Diagnostics revenue growthLucyd revenue growthCardio Diagnostics free cash flowLucyd free cash flow
Cardio Diagnostics & Lucyd appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.